Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874716-25-000062
Filing Date
2025-05-01
Accepted
2025-05-01 16:11:17
Documents
101
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idxx-20250331.htm   iXBRL 10-Q 1558611
2 EX-31.1 idxx2025q110-qexhibit311.htm EX-31.1 10886
3 EX-31.2 idxx2025q110-qexhibit312.htm EX-31.2 10899
4 EX-32.1 idxx2025q110-qexhibit321.htm EX-32.1 5889
5 EX-32.2 idxx2025q110-qexhibit322.htm EX-32.2 6093
11 GRAPHIC idxx-20250331_g1.gif GRAPHIC 6646
  Complete submission text file 0000874716-25-000062.txt   8483467

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20250331.xsd EX-101.SCH 57135
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT idxx-20250331_cal.xml EX-101.CAL 87583
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20250331_def.xml EX-101.DEF 252801
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20250331_lab.xml EX-101.LAB 698980
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20250331_pre.xml EX-101.PRE 504015
104 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20250331_htm.xml XML 1281305
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19271 | Film No.: 25903220
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)